Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-02
DOI
10.3389/fonc.2020.633142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer
- (2019) Lavinia Carabet et al. MOLECULES
- Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells
- (2019) Yongmei Feng et al. CANCER LETTERS
- Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas
- (2019) Vibudh Agrawal et al. MOLECULES
- A polymeric paste-drug formulation for intratumoral treatment of prostate cancer
- (2019) Claudia Kesch et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14 Receptor
- (2018) Jinha Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network
- (2018) Ahn R. Lee et al. EBioMedicine
- Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
- (2017) Fuqiang Ban et al. Journal of Chemical Information and Modeling
- UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
- (2016) Haolong Li et al. CANCER RESEARCH
- Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: the prediction accuracy of sampling power and scoring power
- (2016) Zhe Wang et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- Role of computer-aided drug design in modern drug discovery
- (2015) Stephani Joy Y. Macalino et al. ARCHIVES OF PHARMACAL RESEARCH
- PockDrug: A Model for Predicting Pocket Druggability That Overcomes Pocket Estimation Uncertainties
- (2015) Alexandre Borrel et al. Journal of Chemical Information and Modeling
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
- (2015) Edward Harder et al. Journal of Chemical Theory and Computation
- FAF-Drugs3: a web server for compound property calculation and chemical library design
- (2015) David Lagorce et al. NUCLEIC ACIDS RESEARCH
- Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
- (2015) Haolong Li et al. Oncotarget
- Topoisomerase II and leukemia
- (2014) MaryJean Pendleton et al. Annals of the New York Academy of Sciences
- The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
- (2014) Ning Xie et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
- (2014) Huifang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Consensus Docking: Improving the Reliability of Docking in a Virtual Screening Context
- (2013) Douglas R. Houston et al. Journal of Chemical Information and Modeling
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
- (2013) H. Kuruma et al. MOLECULAR CANCER THERAPEUTICS
- Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
- (2012) Christian Bailly CHEMICAL REVIEWS
- The Structure of DNA-Bound Human Topoisomerase II Alpha: Conformational Mechanisms for Coordinating Inter-Subunit Interactions with DNA Cleavage
- (2012) Timothy J. Wendorff et al. JOURNAL OF MOLECULAR BIOLOGY
- The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication
- (2012) Nuria Pastor et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
- (2011) Peter Axerio-Cilies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Graphical analysis of pH-dependent properties of proteins predicted using PROPKA
- (2011) Michał Rostkowski et al. BMC STRUCTURAL BIOLOGY
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
- (2010) He Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
- (2010) Michael C Haffner et al. NATURE GENETICS
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
- (2009) Chunru Lin et al. CELL
- Regulation of the catalytic function of topoisomerase II alpha through association with RNA
- (2008) S.-W. Park et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started